Here’s what I can share right now about Ramipril recalls.
-
There have been multiple recalls of Ramipril in recent years due to manufacturing issues, including recalls tied to active pharmaceutical ingredients from unapproved vendors and packaging errors. These events have affected varying volumes and batch ranges, with some recalls numbering in the hundreds of thousands of bottles worldwide, and others smaller in scope. These recalls typically involve specific lots or batches and specific strengths or packaging configurations.
-
In the United States, the FDA and manufacturers have issued recalls of Ramipril from at least one major supplier (Lupin Pharmaceuticals) due to concerns about ingredients from unapproved vendors, with hundreds of thousands of bottles affected in late 2024. Some recall notices have included guidance on which lot numbers or strengths to avoid and steps for returning affected products.
-
In the UK and Europe, national regulators have issued precautionary recalls for Ramipril batches when manufacturing or packaging irregularities were detected, sometimes identifying cross-contamination risks or mispacked blister cards, and have advised healthcare professionals and pharmacies to stop dispensing the affected batches and to return stock.
-
Some recalls have involved Ramipril capsules being found to contain different active ingredients (e.g., Amlodipine) due to packaging errors, which can present safety concerns for patients who rely on Ramipril alone. Regulators have issued recalls and safety alerts to mitigate potential risks.
What this could mean for you in Dallas, TX
- If you are currently taking Ramipril, check your medication’s lot/batch number and expiration date against the recall notices from the FDA or your local regulator. Do not stop taking Ramipril abruptly without medical advice, but contact your pharmacist or prescriber if your bottle matches a recalled batch or if you experience unusual symptoms.
- Pharmacies and healthcare providers may have halted distribution of affected batches and arranged returns or replacements; ask your pharmacy to verify whether your Ramipril bottle is affected and what the next steps are.
Next steps I can take for you
- I can look up the most recent recall notices from US and UK regulators and pull the specific batch numbers, strengths affected, and recommended actions. I can also help you verify your bottle’s batch number if you provide its labeling details. Would you like me to fetch the latest official recall notices and summarize the exact batches and actions?
- If you’d like, I can also provide guidance on how to contact your prescribing clinician or local pharmacist for a safer alternative or a replacement if your medicine is recalled.
Citations:
- Recent large Ramipril recalls due to manufacturing issues and unapproved vendors, affecting hundreds of thousands of bottles.[1]
- US FDA-related Ramipril recall details and batch-specific guidance.[3]
- UK/EU precautionary recalls and regulatory responses to Ramipril manufacturing/packaging issues.[4][5]
- Reports of packaging errors introducing other medications (e.g., Amlodipine) into Ramipril lots and subsequent safety alerts.[5][10]
Sources
Health officials have issued an urgent recall for a batch of the common blood pressure medication Ramipril, after discovering a manufacturing error resulted in some capsules containing a different medication, Amlodipine, instead. While both drugs are used to treat high blood pressure, the accidental substitution could lead to side effects like dizziness from lower than normal blood pressure in some patients.
nationaltoday.comOver 600,000 bottles of Ramipril blood pressure medication recalled due to manufacturing issues. Patient safety prioritized.
theheartysoul.comAnyone in possession of the affected batches is being urged to return the medication to their local pharmacy
www.gbnews.comBatch affected GR174091
cpsc.org.ukramipril capsules recall Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. ramipril capsules recall Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for ramipril 5mg capsules. Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that a pack of ramipril 5 mg Capsules (Batch Number GR164099) contains blister strips of Amlodipine 5 mg Tablets inside the...
www.rpharms.comThe MHRA has advised pharmacy and healthcare professionals to stop supplying the impacted batch and return all remaining stock to their suppliers.
www.gov.ukThe Food and Drug Administration has recalled more than 110,000 bottles of blood pressure medication after it was found that a key ingredient in the drugs was compromised.
www.audacy.com